Drs. Russell, Perkins, and Michalek have received research support from Jazz Pharmaceuticals.
1529-0131/asset/olbannerleft.gif?v=1&s=897b81612b4ad6cae003112184adc709261d5f61)
1529-0131/asset/olbannerright.gif?v=1&s=04654f5ea3cbb01656383e0c0d04b16fd0a9a896)
Fibromyalgia
You have full text access to this OnlineOpen article
Sodium oxybate relieves pain and improves function in fibromyalgia syndrome: A randomized, double-blind, placebo-controlled, multicenter clinical trial†
Article first published online: 30 DEC 2008
DOI: 10.1002/art.24142
Copyright © 2008 by the American College of Rheumatology
Additional Information
How to Cite
Russell, I. J., Perkins, A. T., Michalek, J. E. and Oxybate SXB-26 Fibromyalgia Syndrome Study Group (2009), Sodium oxybate relieves pain and improves function in fibromyalgia syndrome: A randomized, double-blind, placebo-controlled, multicenter clinical trial. Arthritis & Rheumatism, 60: 299–309. doi: 10.1002/art.24142
- †
ClinicalTrials.gov identifier: NCT00087555.
Publication History
- Issue published online: 30 DEC 2008
- Article first published online: 30 DEC 2008
- Manuscript Accepted: 5 SEP 2008
- Manuscript Received: 10 AUG 2007
Funded by
- Orphan Pharmaceuticals, a wholly owned subsidiary of Jazz Pharmaceuticals, Palo Alto, California
- Abstract
- Article
- References
- Cited By
Cited in:
- CrossRef
This article has been cited by:
- 1, , , , , , , , , , , Development of responder definitions for fibromyalgia clinical trials, Arthritis & Rheumatism, 2012, 64, 3Direct Link:
- 2, , , , , , , , , Evaluation of Patient-Rated Stiffness Associated With Fibromyalgia: A Post-Hoc Analysis of 4 Pooled, Randomized Clinical Trials of Duloxetine, Clinical Therapeutics, 2012, 34, 4, 824
- 3, The Role of Depression in Chronic Musculoskeletal Pain, Journal of Musculoskeletal Pain, 2012, 20, 1, 5
- 4, The use of sodium oxybate to treat narcolepsy, Expert Review of Neurotherapeutics, 2012, 12, 5, 519
- 5
- 6
- 7, Acute and Chronic Pain Management in Fibromyalgia: Updates on Pharmacotherapy, American Journal of Therapeutics, 2011, 18, 6, 487
- 8, , , , Does Sleep Differ Among Patients with Common Musculoskeletal Pain Disorders?, Current Rheumatology Reports, 2011, 13, 6, 535
- 9, , , Fibromyalgia and Sleep, Best Practice & Research Clinical Rheumatology, 2011, 25, 2, 227
- 10, , Fibromyalgia: from pathophysiology to therapy, Nature Reviews Rheumatology, 2011, 7, 9, 518
- 11
- 12, , , , , , High pain frequency in narcolepsy with cataplexy, Sleep Medicine, 2011, 12, 6, 572
- 13, , , , , , Multidisciplinary approach to fibromyalgia: What is the teaching?, Best Practice & Research Clinical Rheumatology, 2011, 25, 2, 311
- 14, , , , , , Narcolepsy and effectiveness of gamma-hydroxybutyrate (GHB): A systematic review and meta-analysis of randomized controlled trials, Sleep Medicine Reviews, 2011,
- 15, , , Neoteric pharmacotherapeutic targets in fibromyalgia, Expert Opinion on Therapeutic Targets, 2011, 15, 11, 1267
- 16, , , New Concepts in Pain Research and Pain Management of the Rheumatic Diseases, Seminars in Arthritis and Rheumatism, 2011, 41, 3, 319
- 17, , Pharmacological modulation of central nociception in the management of chronic musculoskeletal pain, Pain Management, 2011, 1, 6, 549
- 18, , , Pharmacotherapy of fibromyalgia, Best Practice & Research Clinical Rheumatology, 2011, 25, 2, 285
- 19, , Possible role for glutamic acid decarboxylase in fibromyalgia symptoms: A conceptual model for chronic pain, Medical Hypotheses, 2011, 77, 3, 409
- 20
- 21, Sodium oxybate for the treatment of fibromyalgia, Expert Opinion on Pharmacotherapy, 2011, 1
- 22, , , , , , , Sodium oxybate in the treatment of binge eating disorder: An open-label, prospective study, International Journal of Eating Disorders, 2011, 44, 3Direct Link:
- 23, , , , , , Sodium oxybate reduces pain, fatigue, and sleep disturbance and improves functionality in fibromyalgia: Results from a 14-week, randomized, double-blind, placebo-controlled study, PAIN, 2011, 152, 5, 1007
- 24, , , The use of opioids in fibromyalgia, International Journal of Rheumatic Diseases, 2011, 14, 1Direct Link:
- 25, Tratamiento farmacológico en la fibromialgia, Seminarios de la Fundación Española de ReumatologÃa, 2011, 12, 1, 21
- 26, Treat the symptoms of fibromyalgia with a variety of strategies, as individual therapies provide only moderate benefits, Drugs & Therapy Perspectives, 2011, 27, 1, 17
- 27
- 28
- 29, , A Retrospective Review of the Sleep Characteristics in Patients with Chronic Fatigue Syndrome and Fibromyalgia, Pain Practice, 2010, 10, 4Direct Link:
- 30, , , , , , , Behavioral effects of γ-hydroxybutyrate in humans, Behavioural Pharmacology, 2010, 21, 4, 332
- 31, , , , Duloxetine for the treatment of fibromyalgia, Expert Review of Clinical Immunology, 2010, 6, 5, 745
- 32, Fascia: A missing link in our understanding of the pathology of fibromyalgia, Journal of Bodywork and Movement Therapies, 2010, 14, 1, 3
- 33
- 34
- 35, , Rational treatment of fibromyalgia for a solo practitioner, Best Practice & Research Clinical Rheumatology, 2010, 24, 3, 341
- 36, The Pathophysiology, Diagnosis and Treatment of Fibromyalgia, Psychiatric Clinics of North America, 2010, 33, 2, 375
- 37, , Treatment of the Narcoleptiform Sleep Disorder in Chronic Fatigue Syndrome and Fibromyalgia with Sodium Oxybate, Pain Practice, 2010, 10, 1Direct Link:
- 38, , A symptom-based approach to pharmacologic management of fibromyalgia, Nature Reviews Rheumatology, 2009, 5, 4, 191
- 39, Assessing patients with fibromyalgia from a rheumatologist’s perspective: a three-step methodology for differential diagnosis, International Journal of Clinical Rheumatology, 2009, 4, 4, 409
- 40, Clinical Manifestations and Diagnosis of Fibromyalgia, Rheumatic Disease Clinics of North America, 2009, 35, 2, 215
- 41
- 42
- 43, Fibromyalgia: The diagnosis and pharmacologic treatment, European Journal of Pain Supplements, 2009, 3, S2Direct Link:
- 44, , , , Illicit gamma-hydroxybutyrate (GHB) and pharmaceutical sodium oxybate (Xyrem®): Differences in characteristics and misuse, Drug and Alcohol Dependence, 2009, 104, 1-2, 1
- 45, Narcolepsy and depression and the neurobiology of gammahydroxybutyrate, Progress in Neurobiology, 2009, 89, 2, 193
- 46, , Pharmacotherapy of Fibromyalgia, Rheumatic Disease Clinics of North America, 2009, 35, 2, 359
- 47, , , Potential Dietary Links to Central Sensitization in Fibromyalgia: Past Reports and Future Directions, Rheumatic Disease Clinics of North America, 2009, 35, 2, 409
- 48, Strategies for Managing Fibromyalgia, The American Journal of Medicine, 2009, 122, 12, S31
- 49, The Significance of Dysfunctions of the Sleeping/Waking Brain to the Pathogenesis and Treatment of Fibromyalgia Syndrome, Rheumatic Disease Clinics of North America, 2009, 35, 2, 275
- 50, , Tratamiento farmacológico de la fibromialgia: hacia la neuromodulación quÃmica, ReumatologÃa ClÃnica, 2009, 5, 27